GPR119 Pharmaceutical composition for preventing or treating of nonalcoholic fatty liver disease comprising G protein coupled receptor 119 ligand as an active ingredient

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease, comprising a GPR119 (G protein coupled receptor 119) ligand as an active ingredient, and the pharmaceutical composition according to the present invention improves lipid metabolism, Since it shows an excellent effect of reducing fat accumulation in tissues and preventing histological damage through inflammation and fibrosis of liver tissue, it can be usefully used for the prevention or treatment of non-alcoholic fatty liver disease.